학술논문
Low doses vs. high doses of the angiotensin converting-enzyme inhibitor lisinopril in chronic heart failure: a cost-effectiveness analysis based on the Assessment of Treatment with Lisinopril and Survival (ATLAS) study. The ATLAS Study Group
Document Type
Artikel
Author
Source
European journal of heart failure. 2(4):447-454
Subject
Language
English
English
English
ISSN
1388-9842